| Erin Michelle Fricke, MD | |
|
25 Michigan St Ne Ste 5200, Grand Rapids, MI 49503-2572 | |
| (616) 391-3681 | |
| Not Available |
| Full Name | Erin Michelle Fricke |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 14 Years |
| Location | 25 Michigan St Ne Ste 5200, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003128471 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301096518 (Michigan) | Secondary |
| 207V00000X | Obstetrics & Gynecology | MD-41703 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Health Primary Care Partners | 4587568647 | 1585 |
News Archive
New research from Wake Forest Baptist Medical Center shows that patients suffering from aggressive brain tumors can be effectively treated with smaller radiation fields to spare the rest of the brain and preserve cognition.
Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.
In the run-up to the summit of the G20 countries in November 2020 to be held in Riyadh (Saudi Arabia), the science academies of these countries have presented their joint statement "Foresight: Science for Navigating Critical Transitions".
In a recent study published in the journal Pathogens, researchers carried out a molecular docking study for 17 structural analogs prepared from natural maslinic and oleanolic acids and screened them against SARS-CoV-2 main protease. They also experimentally validated the data by determining the half-maximal cytotoxic and inhibitory concentrations of each of the 17 compounds. The researchers investigated whether the compound with antiviral activity affected viral adsorption, replication, or viricidal effect using a plaque infectivity reduction assay.
› Verified 3 days ago
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
New research from Wake Forest Baptist Medical Center shows that patients suffering from aggressive brain tumors can be effectively treated with smaller radiation fields to spare the rest of the brain and preserve cognition.
Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.
In the run-up to the summit of the G20 countries in November 2020 to be held in Riyadh (Saudi Arabia), the science academies of these countries have presented their joint statement "Foresight: Science for Navigating Critical Transitions".
In a recent study published in the journal Pathogens, researchers carried out a molecular docking study for 17 structural analogs prepared from natural maslinic and oleanolic acids and screened them against SARS-CoV-2 main protease. They also experimentally validated the data by determining the half-maximal cytotoxic and inhibitory concentrations of each of the 17 compounds. The researchers investigated whether the compound with antiviral activity affected viral adsorption, replication, or viricidal effect using a plaque infectivity reduction assay.
› Verified 3 days ago
| Entity Name | Spectrum Health Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558407189 PECOS PAC ID: 8921904764 Enrollment ID: O20040120000997 |
News Archive
New research from Wake Forest Baptist Medical Center shows that patients suffering from aggressive brain tumors can be effectively treated with smaller radiation fields to spare the rest of the brain and preserve cognition.
Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.
In the run-up to the summit of the G20 countries in November 2020 to be held in Riyadh (Saudi Arabia), the science academies of these countries have presented their joint statement "Foresight: Science for Navigating Critical Transitions".
In a recent study published in the journal Pathogens, researchers carried out a molecular docking study for 17 structural analogs prepared from natural maslinic and oleanolic acids and screened them against SARS-CoV-2 main protease. They also experimentally validated the data by determining the half-maximal cytotoxic and inhibitory concentrations of each of the 17 compounds. The researchers investigated whether the compound with antiviral activity affected viral adsorption, replication, or viricidal effect using a plaque infectivity reduction assay.
› Verified 3 days ago
| Entity Name | Mercy Women's Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467476143 PECOS PAC ID: 9133171358 Enrollment ID: O20050216000453 |
News Archive
New research from Wake Forest Baptist Medical Center shows that patients suffering from aggressive brain tumors can be effectively treated with smaller radiation fields to spare the rest of the brain and preserve cognition.
Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.
In the run-up to the summit of the G20 countries in November 2020 to be held in Riyadh (Saudi Arabia), the science academies of these countries have presented their joint statement "Foresight: Science for Navigating Critical Transitions".
In a recent study published in the journal Pathogens, researchers carried out a molecular docking study for 17 structural analogs prepared from natural maslinic and oleanolic acids and screened them against SARS-CoV-2 main protease. They also experimentally validated the data by determining the half-maximal cytotoxic and inhibitory concentrations of each of the 17 compounds. The researchers investigated whether the compound with antiviral activity affected viral adsorption, replication, or viricidal effect using a plaque infectivity reduction assay.
› Verified 3 days ago
| Entity Name | Memorial Medical Center Of West Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972589489 PECOS PAC ID: 3678543659 Enrollment ID: O20071128000647 |
News Archive
New research from Wake Forest Baptist Medical Center shows that patients suffering from aggressive brain tumors can be effectively treated with smaller radiation fields to spare the rest of the brain and preserve cognition.
Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.
In the run-up to the summit of the G20 countries in November 2020 to be held in Riyadh (Saudi Arabia), the science academies of these countries have presented their joint statement "Foresight: Science for Navigating Critical Transitions".
In a recent study published in the journal Pathogens, researchers carried out a molecular docking study for 17 structural analogs prepared from natural maslinic and oleanolic acids and screened them against SARS-CoV-2 main protease. They also experimentally validated the data by determining the half-maximal cytotoxic and inhibitory concentrations of each of the 17 compounds. The researchers investigated whether the compound with antiviral activity affected viral adsorption, replication, or viricidal effect using a plaque infectivity reduction assay.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Michelle Fricke, MD 100 Michigan St Ne # Mc845, Grand Rapids, MI 49503-2560 Ph: () - | Erin Michelle Fricke, MD 25 Michigan St Ne Ste 5200, Grand Rapids, MI 49503-2572 Ph: (616) 391-3681 |
News Archive
New research from Wake Forest Baptist Medical Center shows that patients suffering from aggressive brain tumors can be effectively treated with smaller radiation fields to spare the rest of the brain and preserve cognition.
Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.
In the run-up to the summit of the G20 countries in November 2020 to be held in Riyadh (Saudi Arabia), the science academies of these countries have presented their joint statement "Foresight: Science for Navigating Critical Transitions".
In a recent study published in the journal Pathogens, researchers carried out a molecular docking study for 17 structural analogs prepared from natural maslinic and oleanolic acids and screened them against SARS-CoV-2 main protease. They also experimentally validated the data by determining the half-maximal cytotoxic and inhibitory concentrations of each of the 17 compounds. The researchers investigated whether the compound with antiviral activity affected viral adsorption, replication, or viricidal effect using a plaque infectivity reduction assay.
› Verified 3 days ago
Dr. Marcos Itamar Cordoba Munoz, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 25 Michigan St Ne, Maternal Fetal Medicine Dept, Grand Rapids, MI 49503 Phone: 616-391-3681 | |
Geron D Turke, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1787 Grand Ridge Ct Ne, Suite 201, Grand Rapids, MI 49525 Phone: 616-913-8601 | |
Lisa Anne Andersson-zetye, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2750 E Beltline Ave Ne Fl 1, Grand Rapids, MI 49525 Phone: 616-447-5850 | |
Dr. Andrea C Wolfe, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 329 Saddleback Dr Ne, Grand Rapids, MI 49525 Phone: 616-486-6790 | |
Dr. Mili Thakur, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3230 Eagle Park Dr Ne Ste 100, Grand Rapids, MI 49525 Phone: 616-988-2229 | |
Dr. Gordon Oliver Downey, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 145 Michigan St Ne, Suite 6300, Grand Rapids, MI 49503 Phone: 616-486-6000 Fax: 616-486-2065 |